Tyromotion logo

Tyromotion

Tyromotion makes robotic and sensor-based neurorehabilitation devices, including the Lexo end-effector gait trainer, Amadeo hand robot, Diego arm system and Maya software. The Graz company booked EUR15.6 million (about $18 million) in its fiscal year to March 2025 and expects about EUR25 million for 2026, as majority owner SHS prepares a possible sale.1,3,4,5

Robotics Reviewed Editorial TeamUpdated November 9, 2026tyromotion.com

Our take

Tyromotion sells a full rehab gym rather than one robot. A clinic can cover hand, arm, balance and gait therapy from one supplier and one software platform.1

Its Lexo gait trainer is built for throughput. Short setup and integrated trunk support let therapists treat many different patients a day.3

Scores by criterion

Tyromotion scores out of 10
Pricing transparency3.5
Product maturity7.5
Deployment evidence7.0
Company durability5.5
Ease of integration7.0
Overall score (average of the five)6.1

Each criterion is defined on our methodology page.

Who uses Tyromotion and what it's for

Rehabilitation hospitals and outpatient clinics treating stroke, spinal cord injury and cerebral palsy patients.3

Clinics that want hand, arm, balance and gait devices on one platform.1

History

Alexander Kollreider and David Ram founded Tyromotion in Graz in 2007, starting from a finger-and-hand therapy prototype built for a thesis. Majority owner SHS and the company are preparing a possible sale, and Andreas Mühlenbeck became CEO on November 1, 2026.5,2

Tyromotion GmbH booked EUR15.56 million in revenue for the fiscal year ended March 31, 2025, and expects about EUR25 million and EUR5 million to EUR7 million of EBITDA for 2026. It runs a US subsidiary in Marietta, Georgia.4,5,3

Lexo and the device range

Lexo is an end-effector robotic gait trainer for patients from 15 kg to 180 kg and 100 cm to 200 cm tall, with Pelvis Plus trunk support, active and passive modes and a pediatric kit. It stands 231 cm tall.3

The range also includes Amadeo for fingers and hand, Diego for arm and shoulder, Pablo, Myro, Tymo, Omego Plus, Elvis and the Maya patient management software.3,1

Pricing

Tyromotion quotes devices per clinic, with installation, onboarding, clinical training and maintenance offered as part of its service.1

In 2017 Tyromotion reported an average price of about EUR150,000 per device including software, with 1,500 devices sold to 300 therapy centers.5

Competitive landscape

Which of these companies scores best, and who is each one built for?Hover over or tap a logo for details.
Top rated, for smaller operationsTop rated, for large enterprisesLower score, for smaller operationsLower score, for large enterprises45678910Review Score← Smaller operationsLarge enterprises →Who it's built for6.15.85.96.66.3
Tyromotion and its competitors
CompanyProductPricing modelDeployment footprintWhere Tyromotion wins or loses
TyromotionLexo end-effector gait trainer plus hand, arm and balance devices3About EUR150,000 average per device (2017)5EUR15.56M revenue in FY to March 20254Full device range with fast-setup Lexo gait trainer
HocomaLokomat robotic gait trainer and movement therapy devices7Lokomat Pro FreeD Kombi about EUR881,292 in 20228Definitive debt moratorium to April 9, 20279Hocoma wins on Lokomat evidence and installed base. Tyromotion wins on stability and setup speed.
WandercraftAtalante X and Eve self-balancing exoskeletons18Not published18Devices in more than 700 rehabilitation centers after buying Ekso19Wandercraft wins on hands-free overground walking. Tyromotion wins on clinic throughput.
CyberdyneMedical HAL wearable robot driven by the wearer's bioelectric signals13Not published; mainly rentals and treatment services14Approvals or certifications in more than 20 countries20Cyberdyne wins on bioelectric HAL control. Tyromotion wins on a broader device range.
LifewardReWalk personal exoskeleton and AlterG anti-gravity systems17Medicare fee of $91,032 for a personal exoskeleton16Individual users through Medicare and insurers; AlterG in more than 4,000 facilities16Lifeward wins on personal exoskeletons. Tyromotion wins on clinic-wide therapy systems.

Limits

A pending sale process could change ownership and strategy.5

The new CEO took over on November 1, 2026.5

Lexo is a stationary end-effector trainer, so overground walking practice needs a separate device.3

What customers say

Where it helps

Clinics building a complete robotic rehab gym get the most from Tyromotion.1

High-volume gait programs that need fast patient changeover benefit from Lexo.3

Where it falls short

Clinics wanting overground exoskeleton walking should look at Wandercraft or Lifeward.

Leadership

Sources